(2R)-N-[5-[(1S,3S)-3-[5-[[2-[6-(3,3-difluoroazetidin-1-yl)-2-pyridinyl]acetyl]amino]-1,3,4-thiadiazol-2-yl]cyclohexyl]-1,3,4-thiadiazol-2-yl]-2-hydroxy-2-phenylacetamide

C28H28F2N8O3S2 — CID 90186070

IUPAC(2R)-N-[5-[(1S,3S)-3-[5-[[2-[6-(3,3-difluoroazetidin-1-yl)-2-pyridinyl]acetyl]amino]-1,3,4-thiadiazol-2-yl]cyclohexyl]-1,3,4-thiadiazol-2-yl]-2-hydroxy-2-phenylacetamide
SMILESO=C(Cc1cccc(N2CC(F)(F)C2)n1)Nc1nnc([C@H]2CCC[C@H](c3nnc(NC(=O)[C@H](O)c4ccccc4)s3)C2)s1
InChIInChI=1S/C28H28F2N8O3S2/c29-28(30)14-38(15-28)20-11-5-10-19(31-20)13-21(39)32-26-36-34-24(42-26)17-8-4-9-18(12-17)25-35-37-27(43-25)33-23(41)22(40)16-6-2-1-3-7-16/h1-3,5-7,10-11,17-18,22,40H,4,8-9,12-15H2,(H,32,36,39)(H,33,37,41)/t17-,18-,22+/m0/s1
InChIKeyDHVXIMURILYPRM-NPPFBWRTSA-N
MW626.72 g/mol
LogP4.53
Rot. Bonds9

About (2R)-N-[5-[(1S,3S)-3-[5-[[2-[6-(3,3-difluoroazetidin-1-yl)-2-pyridinyl]acetyl]amino]-1,3,4-thiadiazol-2-yl]cyclohexyl]-1,3,4-thiadiazol-2-yl]-2-hydroxy-2-phenylacetamide

(2R)-N-[5-[(1S,3S)-3-[5-[[2-[6-(3,3-difluoroazetidin-1-yl)-2-pyridinyl]acetyl]amino]-1,3,4-thiadiazol-2-yl]cyclohexyl]-1,3,4-thiadiazol-2-yl]-2-hydroxy-2-phenylacetamide (PubChem CID 90186070) has the molecular formula C28H28F2N8O3S2 and a molecular weight of 626.72 g/mol. Its IUPAC name is (2R)-N-[5-[(1S,3S)-3-[5-[[2-[6-(3,3-difluoroazetidin-1-yl)-2-pyridinyl]acetyl]amino]-1,3,4-thiadiazol-2-yl]cyclohexyl]-1,3,4-thiadiazol-2-yl]-2-hydroxy-2-phenylacetamide.

Molecular Properties

Compound Name(2R)-N-[5-[(1S,3S)-3-[5-[[2-[6-(3,3-difluoroazetidin-1-yl)-2-pyridinyl]acetyl]amino]-1,3,4-thiadiazol-2-yl]cyclohexyl]-1,3,4-thiadiazol-2-yl]-2-hydroxy-2-phenylacetamide
PubChem CID90186070
Molecular FormulaC28H28F2N8O3S2
Molecular Weight626.72 g/mol
Exact Mass626.17
IUPAC Name(2R)-N-[5-[(1S,3S)-3-[5-[[2-[6-(3,3-difluoroazetidin-1-yl)-2-pyridinyl]acetyl]amino]-1,3,4-thiadiazol-2-yl]cyclohexyl]-1,3,4-thiadiazol-2-yl]-2-hydroxy-2-phenylacetamide
SMILESO=C(Cc1cccc(N2CC(F)(F)C2)n1)Nc1nnc([C@H]2CCC[C@H](c3nnc(NC(=O)[C@H](O)c4ccccc4)s3)C2)s1
InChIInChI=1S/C28H28F2N8O3S2/c29-28(30)14-38(15-28)20-11-5-10-19(31-20)13-21(39)32-26-36-34-24(42-26)17-8-4-9-18(12-17)25-35-37-27(43-25)33-23(41)22(40)16-6-2-1-3-7-16/h1-3,5-7,10-11,17-18,22,40H,4,8-9,12-15H2,(H,32,36,39)(H,33,37,41)/t17-,18-,22+/m0/s1
InChIKeyDHVXIMURILYPRM-NPPFBWRTSA-N
XLogP4.53
TPSA146.12 Ų
H-Bond Donors3
H-Bond Acceptors11
Rotatable Bonds9
Heavy Atoms43
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500626.72
LogP ≤ 54.53
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1011

Analyze (2R)-N-[5-[(1S,3S)-3-[5-[[2-[6-(3,3-difluoroazetidin-1-yl)-2-pyridinyl]acetyl]amino]-1,3,4-thiadiazol-2-yl]cyclohexyl]-1,3,4-thiadiazol-2-yl]-2-hydroxy-2-phenylacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2R)-N-[5-[(1S,3S)-3-[5-[[2-[6-(3,3-difluoroazetidin-1-yl)-2-pyridinyl]acetyl]amino]-1,3,4-thiadiazol-2-yl]cyclohexyl]-1,3,4-thiadiazol-2-yl]-2-hydroxy-2-phenylacetamide?
The IUPAC name of (2R)-N-[5-[(1S,3S)-3-[5-[[2-[6-(3,3-difluoroazetidin-1-yl)-2-pyridinyl]acetyl]amino]-1,3,4-thiadiazol-2-yl]cyclohexyl]-1,3,4-thiadiazol-2-yl]-2-hydroxy-2-phenylacetamide (CID 90186070) is (2R)-N-[5-[(1S,3S)-3-[5-[[2-[6-(3,3-difluoroazetidin-1-yl)-2-pyridinyl]acetyl]amino]-1,3,4-thiadiazol-2-yl]cyclohexyl]-1,3,4-thiadiazol-2-yl]-2-hydroxy-2-phenylacetamide.
What is the SMILES notation for (2R)-N-[5-[(1S,3S)-3-[5-[[2-[6-(3,3-difluoroazetidin-1-yl)-2-pyridinyl]acetyl]amino]-1,3,4-thiadiazol-2-yl]cyclohexyl]-1,3,4-thiadiazol-2-yl]-2-hydroxy-2-phenylacetamide?
The canonical SMILES for (2R)-N-[5-[(1S,3S)-3-[5-[[2-[6-(3,3-difluoroazetidin-1-yl)-2-pyridinyl]acetyl]amino]-1,3,4-thiadiazol-2-yl]cyclohexyl]-1,3,4-thiadiazol-2-yl]-2-hydroxy-2-phenylacetamide is O=C(Cc1cccc(N2CC(F)(F)C2)n1)Nc1nnc([C@H]2CCC[C@H](c3nnc(NC(=O)[C@H](O)c4ccccc4)s3)C2)s1.
What is the InChIKey of (2R)-N-[5-[(1S,3S)-3-[5-[[2-[6-(3,3-difluoroazetidin-1-yl)-2-pyridinyl]acetyl]amino]-1,3,4-thiadiazol-2-yl]cyclohexyl]-1,3,4-thiadiazol-2-yl]-2-hydroxy-2-phenylacetamide?
The InChIKey is DHVXIMURILYPRM-NPPFBWRTSA-N. The full InChI is InChI=1S/C28H28F2N8O3S2/c29-28(30)14-38(15-28)20-11-5-10-19(31-20)13-21(39)32-26-36-34-24(42-26)17-8-4-9-18(12-17)25-35-37-27(43-25)33-23(41)22(40)16-6-2-1-3-7-16/h1-3,5-7,10-11,17-18,22,40H,4,8-9,12-15H2,(H,32,36,39)(H,33,37,41)/t17-,18-,22+/m0/s1.
What are the key properties of (2R)-N-[5-[(1S,3S)-3-[5-[[2-[6-(3,3-difluoroazetidin-1-yl)-2-pyridinyl]acetyl]amino]-1,3,4-thiadiazol-2-yl]cyclohexyl]-1,3,4-thiadiazol-2-yl]-2-hydroxy-2-phenylacetamide?
(2R)-N-[5-[(1S,3S)-3-[5-[[2-[6-(3,3-difluoroazetidin-1-yl)-2-pyridinyl]acetyl]amino]-1,3,4-thiadiazol-2-yl]cyclohexyl]-1,3,4-thiadiazol-2-yl]-2-hydroxy-2-phenylacetamide has a molecular weight of 626.72 g/mol, XLogP of 4.53, 9 rotatable bonds, 3 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for (2R)-N-[5-[(1S,3S)-3-[5-[[2-[6-(3,3-difluoroazetidin-1-yl)-2-pyridinyl]acetyl]amino]-1,3,4-thiadiazol-2-yl]cyclohexyl]-1,3,4-thiadiazol-2-yl]-2-hydroxy-2-phenylacetamide is sourced from PubChem (CID 90186070), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).